WEEKLY INSIGHTS | MENA & AFRICA HEALTHCARE MAGAZINE The Surgery Paradox When Patient Growth Stops at the Operating Room Edition: September 2026
eekly
Healthcare operators often celebrate when patient volumes rise.
More outpatient visits. More admissions. More emergency encounters.
More revenue.
But there is a point at which volume growth alone is no longer enough.
The latest performance indicators from
Cleopatra Hospitals Group
provide an interesting case study of this challenge.
The Numbers Tell an Interesting Story
In Q1 2026, Cleopatra Hospitals Group reported approximately
355,035 cases served, representing
9.1% year-on-year growth.
Outpatient visits increased by 8.9% to
289,368, while inpatient activity increased by
10.8% to 17,508.
Revenue reached approximately
EGP 1.97 billion, representing approximately
21.9% year-on-year growth.
Yet one number deserves particular attention:
If the number of patients entering the healthcare system is growing,
why is the number reaching the operating room not growing at the same pace?
Q1 2026 Performance Snapshot
| Indicator | Q1 2026 | YoY Growth | 3-Year CAGR |
|---|---|---|---|
| Cases Served | 355,035 | +9.1% | +12.4% |
| Inpatients | 17,508 | +10.8% | +10.8% |
| Outpatient Visits | 289,368 | +8.9% | +15.2% |
| Surgeries | 9,301 | Flat | +5.0% |
| Revenue | EGP 1.973 Bn | +21.9% | +40.3% |
The Surgery Paradox
The healthcare ecosystem is growing, but the surgical engine is not
growing with it.
This does not necessarily mean that Cleopatra has a problem.
The reported revenue performance demonstrates considerable strength
in monetization and case-mix development.
The deeper management question is whether hospitals are capturing
the full clinical and economic value of the patients they already attract.
Revenue Growth Can Hide a Volume Problem
The contrast between patient activity and revenue is particularly
interesting.
This suggests that the Group is generating considerably more value
from its patient base through a combination of pricing, case mix,
higher-value services and greater capture of patient treatment journeys.
The Operating Room Is Not Just a Room
The operating theatre should not be viewed simply as a physical department.
It is an integrated clinical and economic system.
Patient Acquisition
→
Consultation
→
Diagnosis
→
Treatment Decision
→
Pre-Operative Assessment
→
Surgery
→
Recovery
→
Follow-Up
A failure at any point can prevent an otherwise appropriate surgical
patient from reaching the operating room.
A flat surgical number does not necessarily mean insufficient demand.
It may mean friction somewhere along the patient journey.
Where Could the Missing Surgical Volume Be?
01 — Clinical Conversion
How many outpatient patients are clinically identified as requiring
surgery, and how many actually proceed?
02 — Referral Leakage
How many appropriate patients leave the organization and undergo
treatment elsewhere?
03 — OR Capacity
Is operating-room capacity sufficient, available and efficiently
utilized?
04 — Surgeon Availability
Does the organization have the right surgeons, specialties and
privileges to serve its patient population?
05 — Insurance & Financial Friction
Are authorizations, approvals or financial arrangements delaying
clinically appropriate procedures?
06 — Patient Choice
Are patients choosing competitors because of price, waiting time,
physician preference or perceived quality?
The Surgeon Is a Growth Engine
Surgical volume depends heavily on the organization’s ability to
attract, retain and activate high-performing surgeons.
- Number of active surgeons
- Number of credentialed surgeons
- Number of privileged procedures per surgeon
- Cases per surgeon
- OR utilization by surgeon
- Surgical cancellation rate
- First-case-on-time performance
- Operating-room turnaround time
- Waiting time for surgery
Do we have the right surgeons, with the right privileges, performing
the right procedures, at the right capacity?
The Opportunity Is Not “More Surgery”
More surgeries does not automatically mean better healthcare.
The objective should be:
more appropriate surgeries, delivered safely, efficiently
and at the right clinical quality.
This changes the management philosophy from surgical volume maximization
to clinical pathway optimization.
What Should Hospital CEOs Measure?
The traditional hospital dashboard often measures patients, admissions,
surgeries, revenue and EBITDA.
The next-generation hospital dashboard should go further.
01. OPD → Surgical Indication RateHow many outpatient encounters result in an appropriate surgical indication?
02. Surgical Conversion RateHow many indicated patients actually undergo surgery?
03. Referral Leakage RateHow many eligible surgical cases leave the organization?
04. Surgery Cancellation RateWhy are scheduled procedures cancelled?
05. OR UtilizationHow effectively is available theatre capacity being used?
06. Surgeon ProductivityCases and productive OR hours per surgeon.
07. Revenue per Surgical CaseNot simply the number of surgeries, but the value generated.
08. Surgical Case MixDistribution of low, medium and high-complexity procedures.
A Lesson for MENA & Africa
The Cleopatra example should not be interpreted simply as a
company-specific issue.
It represents a broader challenge for healthcare systems across
MENA and Africa.
Healthcare providers are becoming increasingly sophisticated in
patient acquisition, outpatient expansion, diagnostics, centres of
excellence, digital engagement, insurance contracting and revenue-cycle
management.
But the next competitive frontier may be the ability to manage the
complete patient journey.
From Hospital Management to Patient-Journey Management
The patient does not experience OPD, Radiology, Laboratory, Surgery,
ICU and Ward as separate businesses.
The patient experiences one journey.
The future hospital must therefore integrate:
Patient → Physician → Diagnosis → Treatment Decision → Procedure
→ Surgery → Recovery → Follow-Up
The Strategic Question for 2026
Cleopatra’s Q1 2026 performance demonstrates that healthcare demand
remains strong and that sophisticated hospital operators can generate
significant revenue growth even when certain clinical volumes remain
relatively stable.
But the flat surgical number creates an important management question
for the entire healthcare industry:
When patient volumes are growing faster than surgical volumes,
are we facing a demand problem—or a conversion problem?
The answer will differ from hospital to hospital.
But every hospital CEO should know the answer.
Because in modern healthcare, growth is no longer simply about
attracting more patients.
It is about ensuring that every appropriate patient can move safely,
efficiently and seamlessly through the entire continuum of care.
of the patients we already have.
“`




